Literature DB >> 31415814

CD27 expression of T-cells discriminates IGRA-negative TB patients from healthy contacts in Ghana.

Ernest Adankwah1, Alptekin Güler1, Ertan Mayatepek1, Richard Odame Phillips2, Norman Nausch1, Marc Jacobsen3.   

Abstract

IFN-γ release assays (IGRAs) have suboptimal sensitivity for detection of Mycobacterium tuberculosis (Mtb) infection and cannot discriminate between tuberculosis (TB) patients and healthy -potentially Mtb infected- contacts (HCs). In a case-control study, we determined T-cell phenotypes of IGRAs in TB patients (n = 20) and HCs (n = 20) from Ghana. CD27 expression of T-cells was significantly lower in TB patients as compared to HCs independent from Mtb-specificity. CD27 expression discriminated both study groups - including TB patients with low or indeterminate IGRA results - effectively. We conclude that CD27 is a promising biomarker for diagnosis of TB patients with inconclusive IGRA results.
Copyright © 2019 Institut Pasteur. Published by Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  CD27; Healthy contacts; IFN-γ release assay; T-cells; Tuberculosis

Mesh:

Substances:

Year:  2019        PMID: 31415814     DOI: 10.1016/j.micinf.2019.07.003

Source DB:  PubMed          Journal:  Microbes Infect        ISSN: 1286-4579            Impact factor:   2.700


  2 in total

1.  Plasma cytokine levels characterize disease pathogenesis and treatment response in tuberculosis patients.

Authors:  Monika M Vivekanandan; Ernest Adankwah; Wilfred Aniagyei; Isaac Acheampong; Augustine Yeboah; Joseph F Arthur; Millicent N K Lamptey; Mohammed K Abass; Amidu Gawusu; Francis Kumbel; Francis Osei-Yeboah; Linda Batsa Debrah; Dorcas O Owusu; Alexander Debrah; Ertan Mayatepek; Julia Seyfarth; Richard O Phillips; Marc Jacobsen
Journal:  Infection       Date:  2022-06-27       Impact factor: 3.553

2.  Assessment of CD27 expression on T-cells as a diagnostic and therapeutic tool for patients with smear-negative pulmonary tuberculosis.

Authors:  Haiyun Zhang; Xiaoyan Si; Feifan Xu; Junlin Chen; Yuhao Chen; Xiaopeng Cui; Yongwei Qin
Journal:  BMC Immunol       Date:  2021-06-27       Impact factor: 3.615

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.